The China-Italy Chamber of Commerce (CICC), together with the EU SME Centre and with the support of Confindustria Lombardia, China IP SME Helpdesk, Assolombarda, ENN Enterprise Europe Network and Lombardy’s Life Sciences Cluster, held the online seminar "Overview on China’s Biopharma Sector: Market Access and IP Rights" on September 10th 2021.
Public wellbeing with reference to healthcare and elderly care upgrading is a major objective in China’s 14th Five Years Plan. This opens up opportunities for the European Companies informed on the latest market trends to position themselves in the market.
Our first Speaker Mr. Valtero Canepa, Head for China Region of Bracco Group, and CICC Vice Chairman, discussed how to get prepared for entering and expanding the business in the market taking advantage of the strong growth momentum for pharmaceutical and MedTech, expected to experience an increasingly even higher growth rate.
We also discussed a critical issue in this market which is represented by IP rights protection. Our speaker Mr. Xu Jian, China IPR SME Helpdesk expert and Head of IP practice at the China office of Gowling WLG, provided expert insights on patent and design registration for diagnostic and treatment equipment; insights on preventative measures to minimize the risk of leaking technical secrets; company and product brand protection.
The webinar offered the opportunity to learn more about China’s Biopharma market and explore business opportunities in the field providing companies with the right tools to get prepared for China.
Interested in engaging with companies in this field? CICC Healthcare Working Group offers the opportunity to remain updated on relevant issues. To learn more about the group please contact us at firstname.lastname@example.org.
The CICC Team